A Study of GNC-038 Injection in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
NCT05623982
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Non-hodgkin's Lymphoma
Interventions
DRUG:
GNC-038
Sponsor
Sichuan Baili Pharmaceutical Co., Ltd.
Collaborators
[object Object]
[object Object]